Home/Products /glimepiride-1mg-voglibose-1mg-metformin-hcl-layered-tablets

Vogliviga GM1/0.1 Tablet in PCD pharma franchise in Hyderabad

Name: Vogliviga GM1-0.1 Tablet (Glimepiride I.P. 1mg + Voglibose I.P. 0.1mg + Metformin HCL I.P. 500mg Bi-Layered Tablets)
Brand: Vogliviga GM1- 0.1 Tablet
Rating: 4.8 (150 reviews)

Vogliviga GM1/0.1 Tablet in pharmaceutical manufacturing company in Mumbai

Vogliviga GM1/0.1 Tablet in diabetic pharma franchise in Pune

Vogliviga GM1/0.1 Tablet in pharma suppliers in Delhi

Vogliviga GM1/0.1 Tablet in pharma export companies in Kolkata

Vogliviga GM1/0.1 Tablet in pharma franchise opportunities in Bengaluru

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Glimepiride 1mg + Voglibose 0.1mg + Metformin 500mg Tablet | Antidiabetic Care | Best Price for PCD Pharma Franchise

Glimepiride + Voglibose + Metformin Tablet | Diabetes Management | Best Price from Third-Party Manufacturers in India

Glimepiride 1mg + Voglibose 0.1mg + Metformin | Blood Sugar Control | Best Price from Pharma Export Companies in India

Glimepiride + Voglibose + Metformin Tablet | Oral Antidiabetic | Best Price from Top Pharma Company

Vogliviga GM1/0.1 Tablet | Antidiabetic Care | Best Price in the Antidiabetic Pharma Franchise

Vogliviga GM1- 0.1 Tablet

Composition : Glimepiride I.P. 1mg + Voglibose I.P. 0.1mg + Metformin HCL I.P. 500mg Bi-Layered Tablets

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Please Contact For Best Price

Vogliviga GM1/0.1 Tablet is a triple combination antidiabetic formulation containing Glimepiride 1mg, Voglibose 0.1mg, and Metformin HCl 500mg in a bi-layered tablet form. This formulation provides a synergistic approach to managing type 2 diabetes mellitus. Glimepiride enhances insulin secretion from pancreatic beta cells, Metformin improves insulin sensitivity and decreases hepatic glucose output, while Voglibose delays carbohydrate absorption in the intestine, thereby controlling postprandial glucose spikes. This fixed-dose combination is ideal for patients who need multi-targeted therapy for optimal glycemic control.

About the Product

Patients may experience gastrointestinal discomfort such as bloating, nausea, flatulence, or mild diarrhea. Hypoglycemia can occur, especially if meals are skipped. Long-term use of Metformin may lead to Vitamin B12 deficiency.

Used for the management of type 2 diabetes mellitus in patients who require combination therapy to control fasting and postprandial blood sugar levels effectively.

Not suitable for patients with type 1 diabetes, severe renal or hepatic impairment, or gastrointestinal disorders. Blood glucose levels should be monitored regularly. Avoid alcohol intake during the treatment. Always follow physician guidance for dose adjustments.

Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.